Concepedia
Publication | Closed Access
Vosoritide therapy in children with achondroplasia aged 3−59 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trial
54
Citations
12
References
2023
Year
MedicineVosoritide TherapyPediatricsPaediatric Medicine
Page 1